A dynamic cross-section of business, clinical and biotechnical expertise with a proven track record of providing rapid access to breakthrough therapeutics.
Under the leadership of Chairman and Chief Executive Officer, Mr. Jean-Jacques Bienaimé, BioMarin’s executive management team includes accomplished leaders with deep and broad executive experience. Supported by a staff of approximately 3,000 employees worldwide, we are focused on delivering first-in-class and best-in-class therapeutics to patients with rare genetic diseases.
Leadership Team
Our Pipeline
We take on the biggest challenges in rare disease.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address.
View Now Our Pipeline ⌃Diversity & Inclusion
We value diverse perspectives from a broad spectrum of backgrounds, education, personalities, skill sets, experiences, and knowledge.
Learn More about Diversity and Inclusion at BioMarin ⌃